Moderna to Present at Upcoming Conferences in September 2026
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Moderna (Nasdaq:MRNA) will participate in two investor events in September 2026: the Morgan Stanley 24th Annual Global Healthcare Conference on September 14 at 10:00 a.m. ET, and the Bernstein Insights: Healthcare Leaders and Disruptors 3rd Annual Healthcare Forum on September 23 at 8:50 a.m. ET.
Live webcasts and 30-day replays of both presentations will be accessible under “Events and Presentations” in the Investors section of Moderna’s website.
Details
Market move: MRNA +9.93% in the Sep 1 session. September conference presentations
On Sep 1, the day this news came out, MRNA closed 9.93% above the previous close. Argus tracked a peak move of +5.9% during that session. Our momentum scanner recorded 87 alerts for this stock that day. Relative volume reached 4.4x the daily average during tracking.
Data tracked by StockTitan Argus for the Sep 1 session.
Key Figures
- Morgan Stanley conference date
- September 14, 10:00 a.m. ET
- 24th Annual Global Healthcare Conference
- Bernstein forum date
- September 23, 8:50 a.m. ET
- 3rd Annual Healthcare Forum
- Webcast replay period
- at least 30 days
- Following each presentation
- Morgan Stanley conference number
- 24th
- Annual Global Healthcare Conference
- Bernstein forum number
- 3rd
- Annual Healthcare Forum
Historical Context
-
Priced upsized convertible notes offering; market reaction was negative over 24 hours.
-
FDA approved updated 2026–2027 COVID-19 vaccines for specified populations.
-
Proposed $2.0 billion convertible senior notes private placement preceded negative reaction.
-
INTerpath-001 met recurrence-free and distant metastasis-free survival endpoints.
-
FDA fully approved mFLUSIVA for adults 50 years and older.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Key Terms
mrna technical
AI-generated analysis. How Rhea-AI works. Not financial advice.
CAMBRIDGE, MA / ACCESS Newswire / September 1, 2026 / Moderna, Inc. (Nasdaq:MRNA), today announced its participation in the following upcoming investor conferences:
Morgan Stanley 24th Annual Global Healthcare Conference, on Monday, September 14 at 10:00 a.m. ET
Bernstein Insights: Healthcare Leaders and Disruptors 3rd Annual Healthcare Forum, on Wednesday, September 23 at 8:50 a.m. ET
A live webcast of each of these presentations will be available under "Events and Presentations" in the Investors section of the Moderna website at investors.modernatx.com.
A replay of each webcast will be archived on Moderna's website for at least 30 days following the presentation.
About Moderna
Moderna is a pioneer and leader in the field of mRNA medicine. Through the advancement of its technology platform, Moderna is reimagining how medicines are made to transform how we treat and prevent diseases. Since its founding, Moderna's mRNA platform has enabled the development of vaccines and therapeutics across infectious diseases, cancer, rare diseases and more.
With a global team and a unique culture, driven by the company's values and mindsets, Moderna's mission is to deliver the greatest possible impact to people through mRNA medicines. For more information about Moderna, please visit modernatx.com and connect with us on X, Facebook, Instagram, YouTube and LinkedIn.
Investors:
Lavina Talukdar
Senior Vice President & Head of Investor Relations
617-209-5834
Lavina.Talukdar@modernatx.com
SOURCE: Moderna, Inc.
View the original press release on ACCESS Newswire
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.